Multiplex Biomarker Imaging Market by Application (Drug Safety, Oncology Studies, and Genetic Characterization Studies), by Imaging Techniques (Immuno Fluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent in the Situ Hybridization (FISH) Assay, and Toponome Imaging System (TIS)), and by End-User (Research Institutes Government & Private, Clinical Labs, and Pharmaceutical & Biotechnology): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Global multiplex biomarker imaging market expected to generate revenue of around USD 608.2 million by end of 2024, growing at a CAGR of around 12.3% between 2018 and 2024. Increasing demand for analysis of the diseases and imaging has accelerated the growth of the multiplex biomarker imaging market over the estimated time.

Request Brochure Request Discount

12-Sep-2018 | Number of pages: 110 | Report Code: ZMR-1670 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the multiplex biomarker imaging market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the multiplex biomarker imaging market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the multiplex biomarker imaging market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the multiplex biomarker imaging market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein application, imaging techniques, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Multiplex Biomarker Imaging Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the multiplex biomarker imaging market by segmenting the market based on application, imaging techniques, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Global multiplex biomarker imaging market is divided into its application, imaging techniques, and end-user. On the basis of the application, the market is divided into drug safety, oncology studies, and genetic characterization studies. 

Based on imaging techniques multiplex biomarker imaging market is categorized into immunofluorescence (IF) assay, tissue microarray (TMA) assay, immunohistochemistry (IHC) assay, fluorescent in the situ hybridization (FISH) assay, and toponome imaging system (TIS). 

On the basis of the end user, the multiplex biomarker imaging market is segregated as research institutes government & private, clinical labs, and pharmaceutical & biotechnology.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for multiplex biomarker imaging based on individual segment and application in all the regions and countries.

The report also includes detailed profiles of end players such as Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam Plc., US Biomax Inc., Merck KGaA, ToposNomos Ltd., MicroConstants, Inc., Aushon BioSystems Ltd., Ventana Medical Systems, Inc., Leica Biosystems Nussloch GmbH, Illumina Inc., and others.

This report segments the global multiplex biomarker imaging market as follows:

Global Multiplex Biomarker Imaging Market: By Application

  • Drug Safety
  • Oncology Studies 
  • Genetic Characterization Studies 

Global Multiplex Biomarker Imaging Market: By Imaging Techniques

  • Immuno Fluorescence (IF) Assay
  • Tissue Microarray (TMA) Assay
  • Immunohistochemistry (IHC) Assay
  • Fluorescent in the Situ Hybridization (FISH) Assay
  • Toponome Imaging System (TIS)

Global Multiplex Biomarker Imaging Market: By End User

  • Research Institutes Government & Private
  •  Clinical Labs
  • Pharmaceutical & Biotechnology

Global Multiplex Biomarker Imaging Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

Veterinary Ultrasound Scanners Market: by Scanning Technology (Analog Imaging Technology,Digital Imaging Technology, and Contrast Imaging Technology), by Product Type (Portable Ultrasound Scanners and Cart-Based Ultrasound Scanners), and by End-User (Veterinary Hospitals, Animal Breeding Farms, and Veterinary Clinics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024

Nov-2018 | Price : $ 4899.00 | Pages: 120 | Report Code: ZMR-3524 | Report Format:

The report covers a forecast and an analysis of the veterinary ultrasound scanners market on a global and regional level. The study provides historic data for2015,2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for th...Read More

Molecular Breeding Market: by Marker (Simple Sequence Repeats (SSR), Single Nucleotide Polymorphism (SNP), and Others), by Process (Marker-Assisted Selection (MAS), QTL Mapping, Genomic Selection, Marker-Assisted Backcrossing (MABC), and Others), and by Application (Livestock and Crop): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024

Nov-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3520 | Report Format:

The report covers forecast and analysis for the molecular breeding market on a global and regional level. The study provides historical data from 2015 to 2017along with a forecast from 2018 to 2024based on revenue (USD Billion). The study includes drivers and restraints for the molecular breeding ...Read More

Diabetic Retinopathy Market – by Type (Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy) and by Management (Vitrectomy, Anti-VEGF Therapy, Laser Surgery, and Intraocular Steroid Injection): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017– 2024

Nov-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3504 | Report Format:

The report covers forecast and analysis for the diabetic retinopathymarketon a global and regional level. The study provides historical data from 2015along with a forecast from 2018to 2024based on revenue (USD Billion). The study includes drivers and restraints for the diabetic retinopathymarketal...Read More

Urgent Care Apps Market: by Type (In-hospital Collaboration & Communication Apps, Pre-hospital Triaging &Emergency Care Apps, and Post-hospital Apps) and by Clinical Area (Stroke, Trauma, Cardiac Conditions, and Others): Global Industry Perspective, Comprehensive Analysis,and Forecast, 2017 - 2024

Nov-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3498 | Report Format:

The report covers forecast and analysis for the urgent care appsmarketon a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018to 2024based on revenue (USD Million). The study includes drivers and restraints for the urgent care appsmarketa...Read More

Therapeutic Drug Monitoring Market: by Product (Equipment and Consumables), by Drug Class (Antiarrhythmic Drugs, Antiepileptic Drugs, Antibiotic Drugs,Immunosuppressant Drugs, Psychoactive Drugs, Bronchodilator Drugs, and Others), and by End-User(Commercial/Private Labs, Hospital Labs, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Nov-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3497 | Report Format:

The report covers forecast and analysis for the therapeutic drug monitoringmarketon a global and regional level. The study provides historical data from 2015, 2016, 2017along with a forecast from 2018 to 2024based revenue (USD Billion). The study includes drivers and restraints for the therapeutic...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.